Innovative Stratification of Arrhythmic Risk (ISAR-Trial): Diabetes Mellitus

NCT00196235 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2018-03-12

No results posted yet for this study

Summary

The purpose of this study was to evaluate the performance of established and new risk predictors in predicting mortality in post-infarction patients suffering from diabetes mellitus

Conditions

Sponsors & Collaborators

  • Deutsches Herzzentrum Muenchen

    lead OTHER

Principal Investigators

  • Georg Schmidt, MD · Deutsches Herzzentrum Muenchen

  • Petra Barthel, MD · Deutsches Herzzentrum Muenchen

  • Axel Bauer, MD · Deutsches Herzzentrum Muenchen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1995-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00196235 on ClinicalTrials.gov